Literature DB >> 13679373

The interleukin 1 (IL-1) receptor accessory protein Toll/IL-1 receptor domain: analysis of putative interaction sites in vitro mutagenesis and molecular modeling.

Jurgen Radons1, Stefan Dove, Detlef Neumann, Reinhold Altmann, Alexander Botzki, Michael U Martin, Werner Falk.   

Abstract

The Toll/interleukin 1 (IL-1) receptor family plays an important role in both innate and adaptive immunity. These receptors are characterized by a C-terminal homology motif called the Toll/IL-1 receptor (TIR) domain. A principal function of the TIR domain is mediating homotypic protein-protein interactions in the signal transduction pathway. To suggest interaction sites of TIR domains in the IL-1 receptor complex, we modeled the putative three-dimensional structure of the TIR domain within the co-receptor chain, IL-1 receptor accessory protein. The model was based on homology with the crystal structures of human TLR1 and TLR2. The final structure of the IL-1 receptor accessory protein TIR domain suggests the conserved regions box 1 and 2, including Pro-446, as well as box 3 within the C-terminal alpha-helix as possible protein-protein interaction sites due to their exposure and their electrostatic potential. Pro-446, corresponding to the Pro/His mutation in dominant negative TLR4, is located in the third loop at the outmost edge of the TIR domain and does not play any structural role. Inhibition of IL-1 responsiveness seen after substitution of Pro-446 by charged amino acids is due to the loss of an interaction site for other TIR domains. Amino acids 527-534 as part of the loop close to the conserved box 3 are critical for recruitment of myeloid differentiation factor 88 and to a lesser extent for IL-1 responsiveness. Modeling suggests that native folding of the TIR domain may be approached by the responsive deletion mutants delta528-534 and delta527-533, whereas the C-terminal beta-strand and/or alpha-helix is displaced in the nonresponsive mutant delta527-534.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13679373     DOI: 10.1074/jbc.M306077200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Possible role of receptor heteromers in multiple sclerosis.

Authors:  A O Tarakanov; K G Fuxe; L F Agnati; L B Goncharova
Journal:  J Neural Transm (Vienna)       Date:  2009-02-20       Impact factor: 3.575

2.  Structures and interface mapping of the TIR domain-containing adaptor molecules involved in interferon signaling.

Authors:  Yoshiaki Enokizono; Hiroyuki Kumeta; Kenji Funami; Masataka Horiuchi; Joy Sarmiento; Kazuo Yamashita; Daron M Standley; Misako Matsumoto; Tsukasa Seya; Fuyuhiko Inagaki
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-19       Impact factor: 11.205

3.  Structural basis of the IL-1 receptor TIR domain-mediated IL-1 signaling.

Authors:  Jianjie Zhou; Yu Xiao; Yifei Ren; Jiwan Ge; Xinquan Wang
Journal:  iScience       Date:  2022-06-02

4.  Genetic analysis of Toll/Interleukin-1 Receptor (TIR) domain sequences from rhesus macaque Toll-like receptors (TLRs) 1-10 reveals high homology to human TLR/TIR sequences.

Authors:  Sonali K Sanghavi; Raj Shankarappa; Todd A Reinhart
Journal:  Immunogenetics       Date:  2004-11-11       Impact factor: 2.846

5.  Anti-inflammatory effects of Bifidobacterium longum subsp infantis secretions on fetal human enterocytes are mediated by TLR-4 receptors.

Authors:  Di Meng; Weishu Zhu; Kriston Ganguli; Hai Ning Shi; W Allan Walker
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-08-25       Impact factor: 4.052

6.  A central nervous system-restricted isoform of the interleukin-1 receptor accessory protein modulates neuronal responses to interleukin-1.

Authors:  Dirk E Smith; Brian P Lipsky; Chris Russell; Randal R Ketchem; Jacqueline Kirchner; Kelly Hensley; Yangyang Huang; Wilma J Friedman; Vincent Boissonneault; Marie-Michèle Plante; Serge Rivest; John E Sims
Journal:  Immunity       Date:  2009-05-28       Impact factor: 31.745

7.  Mutational analysis identifies residues crucial for homodimerization of myeloid differentiation factor 88 (MyD88) and for its function in immune cells.

Authors:  Maria Loiarro; Elisabetta Volpe; Vito Ruggiero; Grazia Gallo; Roberto Furlan; Chiara Maiorino; Luca Battistini; Claudio Sette
Journal:  J Biol Chem       Date:  2013-09-09       Impact factor: 5.157

8.  Chronic inflammation in cancer development.

Authors:  Gabriele Multhoff; Michael Molls; Jürgen Radons
Journal:  Front Immunol       Date:  2012-01-12       Impact factor: 7.561

Review 9.  Clash of the Cytokine Titans: counter-regulation of interleukin-1 and type I interferon-mediated inflammatory responses.

Authors:  Katrin D Mayer-Barber; Bo Yan
Journal:  Cell Mol Immunol       Date:  2016-06-06       Impact factor: 11.530

10.  Bile and urine peptide marker profiles: access keys to molecular pathways and biological processes in cholangiocarcinoma.

Authors:  Torsten Voigtländer; Jochen Metzger; Holger Husi; Martha M Kirstein; Martin Pejchinovski; Agnieszka Latosinska; Maria Frantzi; William Mullen; Thorsten Book; Harald Mischak; Michael P Manns
Journal:  J Biomed Sci       Date:  2020-01-03       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.